()Epicatechin Protects Hemorrhagic Brain via Synergistic Nrf2 Pathways
The Numbers That Matter: In the landmark SURMOUNT-5 trial published in the New England Journal of Medicine in May 2025, participants taking tirzepatide lost an average of 20.2% of their body weight over 72 weeks, compared to 13.7% with semaglutide
Other situations requiring prompt communication with your provider include persistent nausea or vomiting lasting more than 24-48 hours, signs of dehydration (decreased urination, dizziness, dry mouth), visual changes, symptoms of hypoglycemia (shakiness, confusion, rapid heartbeat), or unexplained neck mass or hoarseness
& Askjaer, P
Insurance companies have been hesitant to cover the medications when they're prescribed for weight management, which Lasser said could cause problems for WeightWatchers if patients couldn't afford the costly drugs without insurance coverage
These techniques evaluate vasodilation capacity and angiogenic progression
